# reload+after+2024-01-21 21:46:31.522359
address1§7750 El Camino Real
address2§Suite 2A
city§Carlsbad
state§CA
zip§92009
country§United States
phone§858 704 4900
website§https://www.palisadebio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.
fullTimeEmployees§12
companyOfficers§[{'maxAge': 1, 'name': 'Mr. J. D. Finley', 'age': 66, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 573600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ryker  Willie', 'title': 'Senior VP of Finance & Corporate Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mitchell Lawrence Jones M.D., Ph.D.', 'title': 'Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.559
priceToSalesTrailing12Months§19.654284
currency§USD
dateShortInterest§1702598400
forwardEps§-0.95
exchange§NCM
quoteType§EQUITY
shortName§Palisade Bio, Inc.
longName§Palisade Bio, Inc.
firstTradeDateEpochUtc§1175261400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§48a6a4f2-9a74-360b-918d-da0f22330672
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.0
targetLowPrice§1.5
targetMeanPrice§2.25
targetMedianPrice§2.25
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§5.831
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
